What is the primary treatment approach for allergic conjunctivitis?

The primary treatment approach for allergic conjunctivitis focuses on alleviating inflammation and discomfort associated with the allergic reaction, which is why the application of topical anti-inflammatory agents is the correct choice. These agents, such as corticosteroids or non-steroidal anti-inflammatory drugs, help to reduce the swelling, redness, and itching commonly observed in cases of allergic conjunctivitis.

Topical anti-inflammatory agents work directly at the site of inflammation in the conjunctiva, providing faster relief and effectively targeting the underlying cause of symptoms. This localized treatment is essential for managing allergic reactions, as it helps modulate the immune response without the systemic side effects that may accompany oral medications.

While oral antihistamines can be helpful in broader allergy management, they are not as effective in treating the localized symptoms of allergic conjunctivitis compared to topical treatments. Surgical intervention is typically reserved for other ocular conditions and is not appropriate for allergic conjunctivitis. Cold compresses can provide temporary relief by soothing inflammation but do not directly address the underlying cause, making them a supportive rather than primary treatment option.